Mitochondrial dysfunction contributes to oncogene-induced senescence.

Area of Science:

• Cell Biology
• Molecular Biology
• Cancer Research

Background:

• Oncogenic ras expression in human cells induces aberrant proliferation, followed by cell cycle arrest known as cellular senescence.
• Mitochondrial function plays a critical role in cellular processes, including proliferation and senescence.

Purpose of the Study:

• To investigate the role of mitochondria in oncogene-induced senescence.
• To determine the specific mitochondrial changes and their contribution to the senescence phenotype.

Main Methods:

• Analysis of mitochondrial mass, mitochondrial DNA, and reactive oxygen species (ROS) production in cells expressing oncogenic ras.
• Assessment of mitochondrial localization and function during senescence.
• Investigation of the involvement of p53 and Rb tumor suppressor pathways.
• Pharmacological inhibition of mitochondrial electron transport chain and oxidative phosphorylation.

Main Results:

• Cells expressing oncogenic ras showed increased mitochondrial mass, mitochondrial DNA, and ROS production before senescence.
• Dysfunctional mitochondria accumulated near the nucleus in senescent cells, accompanied by oxidative DNA damage, decreased ATP levels, and AMPK activation.
• The increase in mitochondrial mass and ROS was dependent on intact p53 and Rb pathways.
• Direct inhibition of mitochondrial function was sufficient to induce senescence.

Conclusions:

• Mitochondrial dysfunction, characterized by increased ROS and impaired function, is an integral component of oncogene-induced senescence.
• The p53 and Rb tumor suppressor pathways mediate the mitochondrial response to oncogenic ras.
• Targeting mitochondrial pathways could be a therapeutic strategy for cancers driven by oncogenes.